LY303511 displays antiproliferation potential against oral cancer cells in vitro and in vivo-Reference-Cited by-同舟云学术

LY303511 displays antiproliferation potential against oral cancer cells in vitro and in vivo

Published:2019-05-21 Issue:8 Volume:34 Page:958-967
ISSN:1520-4081
Container-title:Environmental Toxicology
language:en
Short-container-title:Environmental Toxicology

Author:

Tang Jen‐Yang¹²,Xu Yi‐Hua³,Lin Li‐Ching⁴⁵⁶,Ou‐Yang Fu⁷⁸,Wu Kuang‐Han³,Tsao Li‐Yi³,Yu Tzu‐Jung⁹,Huang Hurng‐Wern¹⁰,Wang Hui‐Ru¹⁰,Liu Wangta¹¹,Chang Hsueh‐Wei³⁸¹²¹³^ORCID

Affiliation:

1. Department of Radiation Oncology, Faculty of Medicine, College of MedicineKaohsiung Medical University Kaohsiung Taiwan

2. Department of Radiation OncologyKaohsiung Medical University Hospital Kaohsiung Taiwan

3. Department of Biomedical Science and Environmental BiologyKaohsiung Medical University Kaohsiung Taiwan

4. Department of Radiation OncologyChi‐Mei Foundation Medical Center Tainan Taiwan

5. School of MedicineTaipei Medical University Taipei Taiwan

6. Chung Hwa University of Medical Technology Tainan Taiwan

7. Division of Breast Surgery and Department of SurgeryKaohsiung Medical University Hospital Kaohsiung Taiwan

8. Cancer CenterKaohsiung Medical University Hospital Kaohsiung Taiwan

9. Graduate Institute of Medicine, College of MedicineKaohsiung Medical University Kaohsiung Taiwan

10. Institute of Biomedical ScienceNational Sun Yat‐sen University Kaohsiung Taiwan

11. Department of BiotechnologyKaohsiung Medical University Kaohsiung Taiwan

12. Institute of Medical Science and TechnologyNational Sun Yat‐sen University Kaohsiung Taiwan

13. Regenerative Medicine and Cell Therapy Research CenterKaohsiung Medical University Kaohsiung Taiwan

Funder

Kaohsiung Medical University Hospital

Ministry of Science and Technology, Taiwan

Ministry of Health and Welfare, Taiwan

Changhua Christian Hospital

Kaohsiung Medical University

Ministry of Science and Technology

Publisher

Wiley

Subject

Health, Toxicology and Mutagenesis,Management, Monitoring, Policy and Law,Toxicology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/tox.22767

Reference40 articles.

1. In vivo and in vitro ovarian carcinoma growth inhibition by a phosphatidylinositol 3‐kinase inhibitor (LY294002);Hu L;Clin Cancer Res,2000

2. Targeting EMP3 suppresses proliferation and invasion of hepatocellular carcinoma cells through inactivation of PI3K/Akt pathway

3. PI3K signaling in cancer: beyond AKT

4. The PI3K Pathway in Human Disease

5. Phosphoinositide 3-kinase (PI3K) pathway inhibitors in solid tumors: From laboratory to patients

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Functional Pipeline of Genome-Wide Association Data Leads to Midostaurin as a Repurposed Drug for Alzheimer’s Disease;International Journal of Molecular Sciences;2023-07-28

2. Identification and preliminary validation of synovial tissue-specific genes and their-mediated biological mechanisms in rheumatoid arthritis;International Immunopharmacology;2023-04

3. Investigating Cutaneous Squamous Cell Carcinoma in vitro and in vivo: Novel 3D Tools and Animal Models;Frontiers in Medicine;2022-05-09

4. Oxidative Stress-Dependent Synergistic Antiproliferation, Apoptosis, and DNA Damage of Ultraviolet-C and Coral-Derived Sinularin Combined Treatment for Oral Cancer Cells;Cancers;2021-05-18

5. Low Dose Combined Treatment with Ultraviolet-C and Withaferin a Enhances Selective Killing of Oral Cancer Cells;Antioxidants;2020-11-13